SCHEDULE: Nantahala Capital Management Discloses 5.35% Stake in USANA Health Sciences

Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, has reported beneficial ownership of 988,543 shares, representing 5.35% of USANA Health Sciences' common stock as of September 30, 2026.

Summary

• Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, has filed a Schedule 13G.
• As of September 30, 2026, the reporting persons beneficially own 988,543 shares of USANA Health Sciences Inc. common stock.
• This ownership stake represents 5.35% of the class of securities.
• The filing indicates that Nantahala Capital Management, LLC is an investment adviser.
• Wilmot B. Harkey and Daniel Mack are identified as control persons of Nantahala Capital Management, LLC.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily indicating a significant ownership stake without immediate aggressive action, suggesting a 'hold' or 'watch' stance.

Positives

• Significant ownership stake of 5.35% by Nantahala Capital Management, LLC, indicating investor confidence.
• The filing is a Schedule 13G, which is typically for passive investors, suggesting no immediate intent to control or influence the company.

Negatives

• No specific financial performance data or forward-looking statements are included in this ownership filing.
• The filing does not provide details on the investment strategy or rationale behind acquiring the stake.

Risks

• While this is a Schedule 13G filing (passive), any future change in intent by Nantahala Capital Management could impact the stock price.
• Concentration of ownership among a few reporting persons could lead to coordinated actions that may not align with all shareholder interests.

Future Outlook

This filing is an ownership disclosure and does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that significant stakes reported via Schedule 13G filings often precede or coincide with periods of increased investor scrutiny or potential strategic shifts within the health sciences and direct selling industries.

Stakeholder Impact

• Shareholders: May see increased attention on the company's performance and governance due to the significant stake held by Nantahala Capital Management.
• Management: May face increased scrutiny or engagement from Nantahala Capital Management regarding company strategy and performance.

Next Steps

• Monitor future filings from Nantahala Capital Management for any changes in ownership or stated intentions.
• Observe USANA Health Sciences' performance and strategic announcements for potential reactions to increased institutional interest.

Key Dates

Recommendation

The filing indicates a significant passive ownership stake, which is a neutral event in itself. Without further information on Nantahala's intentions or USANA's performance, a 'hold' recommendation is appropriate, suggesting investors monitor the situation.

Keywords

USANA Health Sciences, Nantahala Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Wilmot B. Harkey, Daniel Mack